X4 Pharmaceuticals Inc (XFOR)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
298,432,000
EV to revenue ratio (TTM)
11.21
EV to ebitda
1.1
Financial Performance
Revenue (TTM)
15,847,000
Gross profit (TTM)
12,917,000
EBITDA
-79,004,000
Profitability
Operating margin (TTM)
-186.10%
Profit margin
0.00%
Return on assets (TTM)
-28.10%
Return on equity (TTM)
-113.10%
Per Share Metrics
Revenue per share (TTM)
0.16
EPS
1.38
Diluted EPS (TTM)
1.38
Book value
1.62
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
2.181
Trailing P/E
2.181
Forward P/E
PEG ratio
Price to sales ratio (TTM)
18.83
Price to book ratio (TTM)
1.984
Growth
Quarterly earnings growth (YoY)
346.30%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
5
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.395